bronchiol
obliteran
organ
pneumonia
boop
type
diffus
interstiti
lung
diseas
character
patholog
fibroblast
plug
lumen
respiratori
bronchiol
alveolar
duct
alveoli
variou
lung
diseas
report
patient
infect
human
immunodefici
viru
hiv
report
occurr
boop
hiv
patient
prior
studi
clinic
case
report
korea
describ
uniqu
case
boop
hivinfect
patient
diagnos
surgic
lung
biopsi
success
treat
clarithromycin
femal
admit
histori
cough
sputum
product
histori
fever
diagnos
hiv
infect
year
prior
prescrib
antiretrovir
therapi
medic
art
rilpivirin
mg
onceday
lamivudin
mg
abacavir
mg
onceday
raltegravir
mg
twiceday
poor
adher
due
gastrointestin
troubl
tcell
count
month
admiss
viral
load
suppress
sever
year
admiss
temperatur
respiratori
rate
breath
per
minut
puls
beat
per
minut
blood
pressur
mmhg
auscult
lung
reveal
coars
breath
sound
crackl
bilater
lower
lung
field
complet
blood
cell
count
blood
chemistri
admiss
reveal
white
blood
cell
count
neutrophil
lymphocyt
hemoglobin
level
gdl
platelet
count
arteri
blood
ga
analysi
measur
breath
room
air
show
arteri
oxygen
partial
pressur
mmhg
arteri
carbon
dioxid
partial
pressur
mmhg
oxygen
satur
quantit
realtim
polymeras
chain
reaction
show
hiv
viral
load
copiesml
patient
cell
count
chest
radiographi
admiss
reveal
diffus
bilater
reticular
infiltr
bilater
lung
field
fig
high
resolut
comput
tomographi
ct
scan
show
tini
centrilobular
nodul
treeinbud
pattern
lung
fig
evalu
possibl
communityacquir
bacteri
pneumonia
urin
streptococcu
pneumonia
antigen
ag
test
sputum
legionella
pneumophila
polymeras
chain
reaction
pcr
test
sputum
blood
cultur
done
result
neg
viral
pneumonia
also
consid
pcr
test
perform
detect
adenoviru
respiratori
syncyti
viru
influenza
virus
b
coronaviru
parainfluenza
viru
result
neg
pneumocysti
jirovecii
pcr
aspergillu
galactomannan
ag
assay
cryptococc
ag
test
result
also
neg
consid
cytomegaloviru
cmv
pneumon
cmv
quantit
pcr
reveal
copiesml
howev
patient
clinic
symptom
chest
xray
improv
without
treatment
cmv
miliari
tuberculosi
initi
suspect
antiretrovir
agent
elvitegravir
mg
cobicistat
mg
emtricitabin
mg
tenofovir
mg
antituberculosi
medic
isoniazid
mg
onceday
ethambutol
mg
onceday
pyrazinamid
mg
onceday
rifabutin
mg
timesweek
administ
time
ceftriaxon
g
daili
clarithromycin
mg
twice
daili
administ
clinician
unabl
rule
concurr
bacteri
infect
day
hospit
patient
chest
xray
show
rapid
improv
patient
present
symptom
suggest
inflammatori
connect
tissu
diseas
arthralgia
dri
eye
exposur
histori
irradi
fume
known
caus
inflammatori
injuri
lung
contrari
clinician
initi
suspicion
miliari
tuberculosi
result
interferon
releas
assay
igra
sputum
acidfast
bacilli
afb
stain
tuberculosi
pcr
neg
overal
etiolog
remain
unknown
day
admiss
perform
videoassist
thoracoscop
surgeri
vat
determin
caus
patient
diffus
lung
infiltr
microscop
examin
show
patchi
fibroblast
plug
bronchiol
alveolar
duct
consist
boop
tissu
afb
stain
tuberculosi
pcr
test
neg
fig
antituberculosi
medic
ceftriaxon
discontinu
oral
clarithromycin
mg
twice
day
continu
followup
chest
radiographi
clinic
symptom
cough
sputum
product
improv
prior
discharg
fig
five
month
discharg
patient
asymptomat
normal
chest
xray
furthermor
patient
adher
art
improv
tcell
count
rose
clarithromycin
discontinu
time
patient
current
receiv
regular
outpati
followup
boop
diffus
interstiti
lung
diseas
affect
small
airway
precis
incid
preval
boop
unknown
though
studi
perform
itali
confirm
case
biopsyproven
boop
year
period
singl
center
clinic
featur
diseas
includ
fever
mild
dyspnea
cough
similar
flulik
symptom
pathogenesi
boop
thought
due
epitheli
injuri
follow
format
fibrinoid
inflammatori
cell
cluster
consequ
intraalveolar
fibrosi
patholog
hallmark
boop
presenc
fibroblast
plug
lumen
respiratori
bronchiol
alveolar
duct
alveoli
due
characterist
patholog
find
biopsi
diagnosi
boop
essenti
transbronchi
lung
biopsi
may
perform
videoassist
thoracoscop
lung
biopsi
prefer
techniqu
like
provid
adequ
amount
tissu
boop
occur
result
inflammatori
respons
lung
injuri
good
treatment
respons
seen
broadspectrum
antiinflammatori
agent
corticosteroid
immunemodulatori
macrolid
case
report
describ
treatment
boop
nonhivinfect
patient
macrolid
antibiot
studi
use
hivposit
patient
high
dose
oral
glucocorticoid
therapi
mgkg
per
day
suggest
initi
treatment
patient
sever
symptom
establish
guidelin
regard
durat
treatment
though
total
year
often
recommend
due
frequent
relaps
case
therapi
discontinu
earlier
immunemodulatori
macrolid
treat
mild
diseas
boop
inhibit
proinflammatori
cytokin
product
reason
chanc
boop
hivinfect
patient
may
underdiagnos
consid
area
high
hiv
preval
usual
resourcelimit
lung
biopsi
readili
perform
place
concurr
boop
hiv
infect
report
patient
diagnos
made
via
transbronchi
thoracoscop
biopsi
rapid
treatment
respons
seen
use
corticosteroid
howev
one
case
fatal
pulmonari
aspergillosi
occur
cmv
retin
esophag
occur
two
case
complic
impli
prolong
use
corticosteroid
hivinfect
boop
patient
may
result
fatal
clinic
outcom
secondari
immunocompromis
state
hiv
nonhiv
infect
patient
respond
well
glucocorticoid
therapi
howev
prolong
use
steroid
patient
concomit
hiv
boop
increas
risk
opportunist
infect
mani
known
sideeffect
associ
longterm
use
corticosteroid
macrolid
shown
effect
rel
safe
use
longterm
basi
previou
case
report
allen
et
al
liot
et
al
laguna
del
estal
et
al
santio
et
al
hiv
infect
patient
boop
present
low
cell
count
low
ratio
suggest
sever
immun
defici
may
need
boop
develop
scenario
treat
hivinfect
patient
low
immun
statu
physician
consid
diagnosi
boop
patient
unrespons
treatment
common
condit
pneumocysti
jirovecii
pneumonia
etiolog
unknown
limit
case
report
follow
patient
tcell
count
improv
significantli
time
diagnosi
boop
end
macrolid
treatment
improv
immun
statu
may
provid
protect
opportunist
infect
empir
treatment
ceftriaxon
may
improv
clinic
cours
also
chanc
boop
resolv
spontan
evalu
patient
respons
clarithromycin
treatment
may
accur
reason
summari
case
suggest
macrolid
potenti
treatment
option
hivinfect
patient
mild
boop
case
otherwis
unexplain
unrespons
treatment
boop
taken
consider
surgic
biopsi
perform
confirm
diagnosi
boop
written
inform
consent
obtain
patient
public
case
report
copi
written
consent
avail
review
editor
journal
